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Abstract 
BACKGROUND: Blue nevus is an interesting finding, which aetiology and risk of locoregional and distant 
metastasis have not yet been fully clarified. It may be inherited or acquired, with sporadic cases usually presented 
as solitary lesions. It is often localised in the area of the head and less often on the arms, legs or trunk. Blue nevi 
are formations with relatively low but still possible potential for switching to melanoma. 
CASE REPORT: The patient we described was hospitalised for pronounced cyanosis of the small toe of the right 
foot, accompanied by painful symptoms at rest and pain symptoms for a few weeks. Using inpatient paraclinical 
and instrumental tests, the patient was diagnosed with cholesterol microembolism. During the dermatological 
examination, blue nevus on the contralaterally localised limb was also diagnosed as a sporadic finding. According 
to the patient’s medical history, the finding had existed for many years, but in the last few months, the patient has 
observed growth and progression in the peripheral zone of the nevus without any additional clinical symptoms.  
CONCLUSION: Due to the risk of progression to melanoma, the lesion was removed by radical excision, and the 
defect was closed by tissue advancement flap. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Blue nevi are melanocytic tumours of dermal 
origin. Their prognosis is usually very good, and in 
most cases, they remain completely benign, 
asymptomatic and unchanged throughout life [1]. But 
there is a spectrum of “blue” lesions ranging from 
common benign to lesions of unknown potential as 
heavily pigmented epithelioid melanocytomas to 
aggressive malignant tumours such as the so-called 
“blue nevus associated melanoma” [1] [2] [3] [4). 
According to blue nevi need a thorough histological 
work-up not to overlook a malignant transformation, in 
particular in adult patients where blue nevi are less 
common than in adolescents. Therefore, the dilemma 
often arises whether surgical removal of the nevus 
should be a priority. 
Case report 
 
A 49-years-old man is presented in good 
general status. He was a smoker for 20 years (10-15 
cigarettes per day). There is no evidence of family 
history, concomitant diseases or medication. The 
patient was first hospitalised at the clinic for a blue 
formation on the small toe of the right foot that had 
occurred approximately two weeks before. 
During the dermatological examination, we 
made two independent findings: 1) cyanosis on the 
small toe of the right foot (Fig. 1a, and 2) nevus with 
blue colour on the left leg above the ankle (Fig. 1b, 
1c). The patient complained of pain at palpation of the 
cyanosis toe, foot pain at rest and improvement of the 
status of the movement. 
Case Report 
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The inpatient instrumental and paraclinical 
examinations showed no significant abnormalities: a 
panoramic image of teeth – 17, 23, 27, 32 roots with 
granuloma; PSA (< 4.0) – negative; CEA (< 5.0) – 
negative; Protein C (109.7%) – normal; Protein S 
(119.3%) – normal; antithrombin III – normal; Factor V 
Leiden – normal; anti-phospholipid antibodies – 1.3 
U/ml (< 10); anti-cardiolipin antibodies – 1.4 U/ml (< 
10); anti beta2-glycoprotein antibodies – 3.3 U/ml (< 
10); ANA-1: 100 (boundary titre), anti-streptolysine 
titre – normal; INR – 1.04. 
 
Figure 1: 1a) Cyanotic toe; 1b) Blue nevus localized on the left 
lower leg, above the ankle; 1c) Outlining the resection boundaries; 
1d, 1e) Elliptical excision of the blue nevus with boundaries of 
surgical security 0.5 cm; 1f) Closure of the surgical defect by means 
of stretch plastic surgery 
 
The Doppler echography of the lower limb 
vascular system followed by consultation with a 
vascular surgeon showed no evidence of thrombosis 
or thrombophlebitis. Surface and deep venous system 
– without evidence of reflux; preserved pulsations at 
the levels of the foot and digital arteries of both limbs. 
Echocardiography showed evidence of dilated and 
hypertrophied right ventricle. The blue toe was found 
to be most likely due to cholesterol microembolism. 
For microembolism, a therapy with low 
molecular weight heparin – Nadroparin calcium 
0.4 x 1/d subcutaneously for 7 days and topical 
Heparoid ungentum for 7 days was introduced. After a 
consultation with a vascular surgeon, outpatient 
therapy with Cilostazol 100 mg x 2/d for 1 month and 
Clopidogrel 75 mg x 1/d for 1 month was assigned. 
Due to the patient’s current history of the 
observed growth of a blue formation and the likelihood 
of malignant transformation to melanoma, radical 
removal was performed under local anaesthesia. 
Elliptical excision with a 0.5 cm surgical field security 
was used (Fig. 1d, 1e), followed by gradual closure of 
the defect by tissue advancement flap (Fig. 1f). The 
histological examination confirmed the diagnosis of 
cellular blue nevus with free resection margins. 
 
Discussion 
 
Blue nevus is a flat or slightly raised macula, 
papule or plaque with grey-blue to bluish-black colour 
[2]. It is believed that blue nevi are a collection of 
pigment-producing melanocytes in the dermis [1] [2]. 
They may be congenital or acquired [3]. They are 
usually presented as single lesions and are found in 
the area of the head, neck, and sacral region, the 
back of the upper and lower limbs [1]. In dermoscopy 
with polarised light popular exophytic lesions present 
with a homogenous blue-greyish globular pattern, and 
striking colour changes resembling the colours of a 
rainbow. Such a pattern is usually seen in vascular 
lesions only. In flat lesions, the dermoscopic pattern 
may resemble seborrheic keratosis. Dermoscopy 
alone is not a substitute for histopathology.  
Although in most cases blue nevi are 
considered benign, there are occasions when they are 
likely to progress to melanomas [3] [4] [5]. 
Determination of the risk of occurrence of a possible 
melanoma based on a blue nevus, as well as which of 
the occurred or congenital blue nevi will have an 
aggressive course, may be a significant challenge for 
the clinician [3] [4]. In these cases, identification of 
certain genetic changes would help to individualise 
and refine their prognosis [4].  
Benign and malignant lesions are 
characterised by genetic peculiarities. Benign blue 
nevi harbour mutations of the G-protein-coupled 
receptor subunits GNAQ and GNA11. Also, the c-kit 
(CD117) gene may be used, which is strongly positive 
in immunohistochemical staining for benign cellular 
blue nevi, in contrast to the invasive melanomas, in 
which this gene has a lower intensity of staining [1].  
Several histological types of blue nevi are 
known: simple blue nevus, cellular blue nevus, 
atypical cellular blue nevus, combined blue nevus, 
blue nevus-like melanoma, and malignant blue nevus 
– with the worst prognosis [3] [4] [5].  
The frequency of malignant transformation of 
blue nevi is between 5.2 and 6.3% [6]. No consensus 
has yet been reached on the histological features 
indicating malignancy in blue nevi, and this poses 
significant diagnostic difficulties in attempting to 
distinguish between benign and malignant blue nevus 
[7]. The presence of irregular edges with satellites 
(satellitosis) is considered a strong precondition for 
malignancy [5]. Other signs considered to be 
indicative of possible malignant transformation are 
infiltration boundaries, common mitoses, nuclear 
pleomorphism, hyperchromasia [7]. According to 
many authors, the most important histopathological 
sign distinguishing benign and malignant blue nevi is 
the widespread necrosis [7]. 
Malignant blue nevi are “aggressive 
neoplasias” that most commonly metastasises in the 
regional lymph nodes [3] [6] [9]. Migration or infiltration 
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of nevus cells to distant lymph nodes is also possible 
[8]. Interestingly, it is possible to have infiltration of the 
lymph nodes by single cells also in the event of a 
benign type of cellular blue nevus without any 
histological evidence of malignancy [1] [6] [10]. 
Literature data are of interest, in which axillary lymph 
node biopsy (performed to suspicion of breast cancer 
metastasis) indicates the presence of a combined 
blue nevus adjacent to benign non-pigmented nevus 
cells (within the same lymph node). This speaks in 
favour of the fact that blue nevus may occur as a 
primary finding in the lymph nodes without a skin 
manifestation or primary skin manifestation [11]. 
Virtually, the cases of enlarged lymph nodes 
within the congenital or acquired cellular blue nevus 
camouflage the clinical picture and may be 
misinterpreted as melanoma metastases [12].  
Atypical cellular blue nevus is presented with 
median histology between the “malignant blue nevus” 
and melanoma [3]. This type of blue nevus is 
associated with the highest risk of proliferation to 
malignant melanoma and metastasis in the lymph 
nodes [3] [13]. There are in fact cases of “metastatic 
malignant melanoma”, which are often the result of 
incorrect diagnosis or interpretation of the available 
histopathological evidence indicative of a “malignant 
blue nevus” [13]. 
As on many other topics in the field of 
medicine, there are many questions here as well [14]. 
On the one hand, the underestimated blue nevi may 
become melanomas with metastasis in the lymph 
nodes, and on the other, the lymph nodes that are not 
always enlarged, in combination with blue nevus show 
progression to malignant melanoma [11] [13] [16]. 
According to studies evaluating the 5-years survival in 
cases of lymph nodes involvement from benign nevus 
cells, it does not differ from that in patients lacking 
lymph nodes involvement [17]. Currently, the 
recommended approach in case of lymph nodes 
involvement is the removal of the primary skin lesion 
and lymph nodes biopsy, followed by histological and 
immunohistochemical analysis to consider further 
actions [17]. 
Several years after lymph nodes dissection 
has seemed to be mandatory for the detection of a 
malignant blue nevus with lymph nodes metastases 
[18]. Complete lymph node dissection is seen today 
more critical especially in patients with low-risk 
sentinel lymph node tumour load since the prognosis 
is not improved by this way [19] [20]. 
A case of a patient with a blue nevus leading 
to the development of orbital-palpebral and 
intracranial melanoma has also been described [21]. 
Any case of increasing and extending blue 
nevus boundaries is a major indication of their surgical 
removal [7] [11]. The excision should be through a 
technique leading to complete elimination of the lesion 
and should ensure compliance with the boundaries of 
surgical security [22]. This is easily and quickly 
accomplished by radical excision and closing the 
defect using a tissue advancement flap [20]. Each 
patient with a resected blue nevus requires a 
histological examination of the lesion removed and 
long-term monitoring of the operative zone and the 
locoregional lymph nodes [6] [11] [14]. 
In conclusion, despite the “predominantly” 
benign course of the blue nevi, some of them are 
related to a risk of switching to malignant melanoma. 
This makes the early surgical removal a priority 
approach. The aesthetically and therapeutically 
acceptable surgical decision for blue nevi is the 
radical excision, followed by closure of the occurred 
skin defect using stretch plastic surgery. 
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